d-Fenfluramine treatment of binge eating disorder

American Journal of Psychiatry

Volumn 153, Issue 11, 1996, Pages 1455-1459

  Stunkard, Albert ^a,b   Berkowitz, Robert ^a   Tanrikut, Cigdem ^a   Reiss, Elizabeth ^a   Young, Lisa ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE;

APPETITE; ARTICLE; BULIMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOOD INTAKE; HUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0029957925     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.11.1455     Document Type: Article

References (30)

1. Stunkard AJ: Eating patterns and obesity. Psychiatr Q 1959; 33: 284-294
2. Yanovski SZ: Binge eating disorder: current knowledge and future directions. Obesity Res 1993; 1:306-324
3. Spitzer RL, Devlin M, Walsh BT, Hasin D, Wing R, Marcus M, Stunkard A, Wadden T, Yanovski S, Agras S, Mitchell J, Nonas C: Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eating Disorders 1992; 11:191-203
4. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL: Binge eating disorder: its further validation in a multisite study. Int J Eating Disorders 1993; 13:137-153
5. Gormally J, Black S, Daston S, Rardin D: The assessment of binge eating severity among obese persons. Addict Behav 1982; 7:47-55
6. Loro AD, Orleans CS: Binge eating in obesity: preliminary findings and guidelines for behavioral analysis treatment. Addict Behav 1981; 6:155-166
7. Marcus MD, Wing RR, Lamparski DM: Binge eating and dietary restraint in obese patients. Addict Behav 1985; 10: 163-165
8. Stunkard A, Berkowitz R, Wadden T, Tanrikut C, Reiss E, Young L: Binge eating disorder and the night-eating syndrome. Int J Obesity 1996; 20:1-6
9. Yanovski SZ, Nelson JE, Dubbert BK, Spitzer RL: Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993; 150:1472-1479; correction, 150: 1910
10. Kuehnel RH, Wadden TA: Binge eating disorder, weight cycling, and psychopathology. Int J Eating Disorders 1994; 15:321-329
11. Bruce B, Agras WS: Binge eating in females: a population-based investigation. Int J Eating Disorders 1992; 12:365-373
12. Telch CF, Agras WS, Rossiter EM: Binge eating increases with increasing adiposity. Int J Eating Disorders 1988; 7:115-119
13. Keefe PH, Wyshgrod D, Weinberger E, Agras WS: Binge eating and outcome of behavioral treatment of obesity: a preliminary report. Behav Res Ther 1984; 2:319-321
14. Marcus MD, Wing RR, Hopkins J: Obese binge caters: affect, cognitions, and response to behavioral weight control. J Consult Clin Psychol 1988; 56:433-439
15. Telch CF, Agras WS, Rossiter EM, Wilfley D, Kenardy J: Group cognitive-behavioral treatment for the nonpurging bulimic: an initial evaluation. J Consult Clin Psychol 1990; 58:629-635
16. Wilfley DE, Agras WS, Telch CF, Rossiter EM, Schneider JA, Cole AG, Sifford L, Raeburn SD: Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol 1993; 61:296-305
17. Smith DE, Marcus MD, Kaye W: Cognitive-behavioral treatment of obese binge eaters, Int J Eating Disorders 1992; 12:257-262
18. McCann UD, Agras WS: Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990; 147:1509-1513
19. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ: Effect of a tricyclic antidepressant and opiate antagonist on hinge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991; 53:865-871
20. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W: A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 1990; 147:876-881
21. Gardiner HM, Freeman CPL, Jesinger DK, Colins SA: Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing. Int J Obesity 1993; 17:301-305
22. Overweight and Dexfenfluramine: A Perspective for the 1990s. Int J Obesity 1992; 16(suppl 3)
23. McTavish D, Heel RC: Dexfenfluramine: a review of its pharmacological properties and therapeutic potential in obesity. Drug Evaluation 1992; 43:713-733
24. Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P: International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2:1142-1145
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
26. Stunkard AJ, Messick S: The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29:71-83
27. Feldman HA: Families of lines: random effects in linear regression analysis. J Appl Physiol 1988; 64:1721-1732
28. Cohen J: Statistical Power Analysis for the Behavioral Sciences, New York, Academic Press, 1969, pp 22-25
29. Mathus-Vliegen EMH, van de Voorde K, Kok AME, Res AMA: Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behavior. J Intern Med 1992; 232:119-127
30. Andersen T, Astrup A, Quaade F: Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial, Int J Obesity 1992; 16:35-40